Francesco Bellanti
Francesco Bellanti is an expert in Internal medicine at University of Foggia (Italy). Francesco Bellanti has authored 160 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 522 (community average: 125). How the SLR is computed.
LeadR Profile
Internal medicine
Subspecialties: Nutrition - Biochemistry - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 160
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The C-Reactive Protein/Albumin Ratio Predicts In-Hospital Mortality Across Age Groups. PMID 42796971 — mortality, c-reactive protein, hospital mortality, food, roc curve | Nutrients | 2026 | 0 |
| Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry. PMID 42118390 — registries, inappropriate prescribing, drug prescriptions, pharmaceutical preparations, internal medicine, cohort studies, prescriptions, aged, prevalence, prescription drugs | Intern Emerg Med | 2026 | 0 |
| Insulin Growth Factor Binding Protein-6 and the Liver. PMID 41511360 — cells, hepatic stellate cells, carcinoma, hepatocellular, growth, insulin, protein kinases, neoplasms, liver, insulin-like growth factor binding proteins, therapeutics, cholangiocarcinoma | Cells | 2026 | 0 |
| Malnutrition Is Associated with Increased Liver Stiffness in Type 2 Diabetes: The Mediating Role of Inflammation. PMID 41463388 — diabetes mellitus, malnutrition, fibrosis, liver, diabetes mellitus, type 2, liver stiffness | Biomolecules | 2025 | 0 |
| Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry. PMID 41372660 — registries, anticoagulants, internal medicine, proton pump inhibitors, therapeutics, proton pumps | Intern Emerg Med | 2025 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Tumors and Respiratory System Diseases Due to Air Pollution New Biomarkers of Exposure and Effects NCT06800586 — cells, chronic disease, lung, environmental pollutants, respiratory system, air pollution, smokers, neoplasms, carcinoma, non-small-cell lung, leukemia, biomarkers, air, pulmonary disease, chronic obstructive, lung neoplasms, environmental pollution, lung diseases, carcinoma | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map